Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109795454> ?p ?o ?g. }
- W2109795454 endingPage "239" @default.
- W2109795454 startingPage "234" @default.
- W2109795454 abstract "We report the results of a non-randomized phase II study of low-dose thalidomide plus low-dose dexamethasone therapy in 66 patients with refractory multiple myeloma. The overall response rate (near complete, partial and minimal response) was 63.6%, and progression-free and overall survival periods were 6.2 and 25.4 months. In adverse events, the incidence of peripheral neuropathy and deep vein thrombosis was lower than the data reported in USA and Europe. On the other hand, leukopenia was observed in 41% of patients, including 11% of those with Grade 3. Leukopenia was closely related to pretreatment pancytopenia, especially thrombocytopenia. The incidence of adverse events related to dexamethasone was low. In conclusion, low-dose thalidomide plus low-dose dexamethasone therapy was as effective as high-dose thalidomide plus high-dose dexamethasone therapy in patients with refractory multiple myeloma. Leukopenia is one of the most serious adverse events in Japanese patients, especially in patients with pretreatment pancytopenia." @default.
- W2109795454 created "2016-06-24" @default.
- W2109795454 creator A5000604213 @default.
- W2109795454 creator A5001924375 @default.
- W2109795454 creator A5014768666 @default.
- W2109795454 creator A5017171769 @default.
- W2109795454 creator A5026762883 @default.
- W2109795454 creator A5027081795 @default.
- W2109795454 creator A5033838383 @default.
- W2109795454 creator A5036980000 @default.
- W2109795454 creator A5039755665 @default.
- W2109795454 creator A5042551306 @default.
- W2109795454 creator A5054315130 @default.
- W2109795454 creator A5061850393 @default.
- W2109795454 creator A5065648065 @default.
- W2109795454 creator A5066174292 @default.
- W2109795454 creator A5067288478 @default.
- W2109795454 creator A5068511697 @default.
- W2109795454 creator A5076119019 @default.
- W2109795454 creator A5078839273 @default.
- W2109795454 creator A5081363686 @default.
- W2109795454 creator A5086871589 @default.
- W2109795454 creator A5088707445 @default.
- W2109795454 date "2007-06-20" @default.
- W2109795454 modified "2023-10-13" @default.
- W2109795454 title "Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma" @default.
- W2109795454 cites W1972996664 @default.
- W2109795454 cites W1985147506 @default.
- W2109795454 cites W1988605844 @default.
- W2109795454 cites W2005850131 @default.
- W2109795454 cites W2013357246 @default.
- W2109795454 cites W2066671330 @default.
- W2109795454 cites W2078178871 @default.
- W2109795454 cites W2092350087 @default.
- W2109795454 cites W2095462726 @default.
- W2109795454 cites W2113101033 @default.
- W2109795454 cites W2126984032 @default.
- W2109795454 cites W2127206962 @default.
- W2109795454 cites W2132242107 @default.
- W2109795454 cites W2163572210 @default.
- W2109795454 cites W2316160054 @default.
- W2109795454 cites W3028447306 @default.
- W2109795454 cites W4236730981 @default.
- W2109795454 cites W4254235859 @default.
- W2109795454 cites W4376542883 @default.
- W2109795454 doi "https://doi.org/10.1111/j.1600-0609.2007.00908.x" @default.
- W2109795454 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17655699" @default.
- W2109795454 hasPublicationYear "2007" @default.
- W2109795454 type Work @default.
- W2109795454 sameAs 2109795454 @default.
- W2109795454 citedByCount "30" @default.
- W2109795454 countsByYear W21097954542012 @default.
- W2109795454 countsByYear W21097954542013 @default.
- W2109795454 countsByYear W21097954542014 @default.
- W2109795454 countsByYear W21097954542015 @default.
- W2109795454 countsByYear W21097954542018 @default.
- W2109795454 countsByYear W21097954542020 @default.
- W2109795454 countsByYear W21097954542022 @default.
- W2109795454 crossrefType "journal-article" @default.
- W2109795454 hasAuthorship W2109795454A5000604213 @default.
- W2109795454 hasAuthorship W2109795454A5001924375 @default.
- W2109795454 hasAuthorship W2109795454A5014768666 @default.
- W2109795454 hasAuthorship W2109795454A5017171769 @default.
- W2109795454 hasAuthorship W2109795454A5026762883 @default.
- W2109795454 hasAuthorship W2109795454A5027081795 @default.
- W2109795454 hasAuthorship W2109795454A5033838383 @default.
- W2109795454 hasAuthorship W2109795454A5036980000 @default.
- W2109795454 hasAuthorship W2109795454A5039755665 @default.
- W2109795454 hasAuthorship W2109795454A5042551306 @default.
- W2109795454 hasAuthorship W2109795454A5054315130 @default.
- W2109795454 hasAuthorship W2109795454A5061850393 @default.
- W2109795454 hasAuthorship W2109795454A5065648065 @default.
- W2109795454 hasAuthorship W2109795454A5066174292 @default.
- W2109795454 hasAuthorship W2109795454A5067288478 @default.
- W2109795454 hasAuthorship W2109795454A5068511697 @default.
- W2109795454 hasAuthorship W2109795454A5076119019 @default.
- W2109795454 hasAuthorship W2109795454A5078839273 @default.
- W2109795454 hasAuthorship W2109795454A5081363686 @default.
- W2109795454 hasAuthorship W2109795454A5086871589 @default.
- W2109795454 hasAuthorship W2109795454A5088707445 @default.
- W2109795454 hasConcept C120665830 @default.
- W2109795454 hasConcept C121332964 @default.
- W2109795454 hasConcept C126322002 @default.
- W2109795454 hasConcept C134018914 @default.
- W2109795454 hasConcept C141071460 @default.
- W2109795454 hasConcept C142424586 @default.
- W2109795454 hasConcept C197934379 @default.
- W2109795454 hasConcept C2776364478 @default.
- W2109795454 hasConcept C2776694085 @default.
- W2109795454 hasConcept C2779382419 @default.
- W2109795454 hasConcept C2779609412 @default.
- W2109795454 hasConcept C2779901536 @default.
- W2109795454 hasConcept C2780007613 @default.
- W2109795454 hasConcept C2780401358 @default.
- W2109795454 hasConcept C2780873365 @default.
- W2109795454 hasConcept C555293320 @default.
- W2109795454 hasConcept C61511704 @default.
- W2109795454 hasConcept C71924100 @default.